Seek immediate medical attention for: Severe, persistent abdominal pain, especially if different from typical IBS pain or radiating to the back (possible pancreatitis) Persistent vomiting preventing adequate fluid intake Signs of dehydration (decreased urination, dizziness, extreme thirst) Severe constipation lasting more than 3-4 days without bowel movement Blood in stool or black, tarry stools Yellowing of skin/eyes, right upper quadrant pain (possible gallbladder disease) Markedly reduced urination (possible acute kidney injury) Fever accompanying gastrointestinal symptoms Neck mass, difficulty swallowing, persistent hoarseness (thyroid concerns) Allergic reactions (rash, itching, swelling, severe dizziness) Scheduled follow-up should occur within 4-6 weeks of initiating therapy and after each dose escalation
Perricone, C., Caterina De Carolis, & Perricone, R
As already mentioned, GSTP1-1 is over-expressed in several cancers where it protects cells from cell death by inhibiting the activity of JNK or its upstream activation
If you don't feel comfortable talking to your doctor, please engage with our drug checking and harm reduction services
Many patients find that nausea often improves during or after the dose titration period as their body adjusts to the medication
after two weeks, about 25%